Rate Notice: 5.9% general rate increase Jan 1, 2026 — Learn More
    The granulesusainc logo features a stylized blue wave encompassing a central red circle representing the companys brand

    Granules Usa Inc.

    Granules USA Inc. is a leading importer and distributor of generic pharmaceutical products, serving the U.S. market with high-quality, affordable medicines from its base in Parsippany, New Jersey.

    Company Overview

    Granules USA Inc. operates as the U.S. distribution arm of Granules India Limited, a global pharmaceutical manufacturer. The company specializes in importing, distributing, and marketing generic pharmaceuticals, leveraging its parent company’s manufacturing strength. Granules USA Inc. plays a key role in supplying essential medicines to the U.S. healthcare market.

    Key Metrics

    3,044

    Import Shipments

    2

    Distribution Centers

    150.0M

    Annual Revenue

    2010

    Founded

    Company Profile

    Key Milestones

    Important company milestones and achievements.

    Markets Served

    Geographic markets and customer segments served.

    Ownership Structure

    Corporate ownership and organizational structure.

    Sales Channels

    Distribution networks and sales approaches.

    Recent Developments

    Granules USA Inc. is likely focused on expanding its generic drug portfolio, enhancing supply chain resilience, and meeting increased demand for affordable pharmaceuticals in the U.S. market.

    Strategic Expansion

    Expansion of import volumes and product offerings to address growing demand for generics

    Market Expansion

    Strategic efforts to expand market presence and reach new customer segments.

    Technology Adoption

    Implementation of advanced technologies to improve service delivery and customer experience.

    Business Information

    Granules USA Inc. focuses on the import and distribution of generic pharmaceutical products, including widely used medications such as Paracetamol, Ibuprofen, and Metformin. The company acts as a critical link between Granules India’s manufacturing operations and the U.S. pharmaceutical supply chain, ensuring timely delivery and regulatory compliance. With a strong presence in the generic drug market, Granules USA Inc. supports healthcare providers and pharmacies across the United States. Its operations are centered in Parsippany, New Jersey, facilitating efficient logistics and customer service.

    Headquarters

    Parsippany, New Jersey

    Founded

    2010

    Stock Symbol

    Private company